LUCENTIS (RANIBIZUMAB)
LUCENTIS is indicated for the treatment of patients with: LUCENTIS, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with: Neovascular…
Genentech, Inc. Products: Prescription Medications Section, Page 5
Nutropin AQ NuSpin 5 (Somatropin)
Nutropin AQ is a recombinant human growth hormone indicated for: Pediatric Patients: Treatment of children with growth failure due to growth hormone deficiency (GHD), idiopathic short…
OCREVUS (Ocrelizumab)
OCREVUS is indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary…
Pegasys (Peginterferon Alfa-2a)
PEGASYS is an inducer of the innate immune response indicated for the treatment of. Chronic Hepatitis C (CHC) (1.1) Adult Patients: In combination therapy with other hepatitis C virus…
PERJETA (Pertuzumab)
PERJETA is a HER2/neu receptor antagonist indicated for: Use in combination with trastuzumab and docetaxel for treatment of patients with HER2-positive metastatic breast cancer (MBC) who…